Given the high drop-out rates frequently noted in drug trials with bulimic subjects, we have attempted to correlate drop-out status with a greater level of psychopathology as measured by a thorough standardized psychological assessment battery (NIMH-DIS, EDI, POMS and SCL-90). Despite a trend toward higher scores on the Paranoid Ideation Sub scale of the SCL-90 among drop-outs compared to completers, there were no significant differences found between the two groups participating in a fifteen week double blind crossover study on the effectiveness of desipramine in bulimia.
Get full access to this article
View all access options for this article.
References
1.
LaskyJ. L., The Problem of Sample Attrition in Controlled Treatment Trials, Journal of Nervous and Mental Disease, 135, pp. 332–337, 1962.
2.
MinolettiA.PérezE., and BlouinA., Compliance with Referrals from Psychiatric Emergency Services to Ambulatory Facilities: A 20-year Literature Review, American Journal of Social Psychiatry, 4, pp. 57–61, 1984.
3.
HaynesR. B., A Critical Review of the Determinants of Patient Compliance with Therapeutic Regiments, in Compliance in Health Care, HaynesR. B.TaylorD. W. and SachettD. L. (eds.), Johns Hopkins University Press, Baltimore, 1979.
4.
MushlinA. A. and AppelF. A., Diagnosing Potential Noncompliance: Physician's Ability in a Behavioural Dimension of Medical Care, Archives of Internal Medicine, 137, pp. 318–321, 1977.
5.
WalshB. T.StewartJ. W.RooseS. P.GladisM., and GlassmanA. H., Treatment of Bulimia with Phenelzine, Archives of General Psychiatry, 41, pp. 1105–1109, 1984.
6.
PopeH.HudsonJ. I.JonasJ. M., and Yurgelun-ToddD., Bulimia Treated with Imipramine: A Placebo Controlled Double Blind Study, American Journal of Psychiatry, 140, pp. 554–558, 1983.
7.
CaldwellJ. R.CobbS.DowlingM. D., and de JonghD., The Drop-out Problem in Antihypertension Treatment, Journal of Chronic Diseases, 22, pp. 579–592, 1970.
8.
GlanzK.FielS. B.SwartzM. A., and FrancisM. E., Compliance with an Experimental Drug Regimen for Treatment of Asthma: Its Magnitude, Importance and Correlates, Journal of Chronic Diseases, 37, pp. 815–824, 1984.
9.
SabineE. J.YonaceA.FarringtonA. J.BarrattK. H., and WakelingA., Bulimia Nervosa: A Placebo Controlled Double Blind Therapeutic Trial of Mianserin, British Journal of Clinical Pharmacology, 15, pp. 1955–2025, 1983.
10.
CattellR., The 16PF, Institute for Personality and Ability Testing, Champaign, Illinois, 1972.
11.
KaplanI. K. and SadockB. J. (eds.), Comprehensive Textbook of Psychiatry, 4th edition, Williams and Wilkins, pp. 474–476, 1985.
12.
O'HalloranM. W.ZacestR.BarrowC. G., and WilsonL. L., Suspiciousness Trait: A Factor in Antihypertensive Drug Trials, The Lancet, 2, pp. 8155, 1979.
13.
JanowskyD. S.ByerlyB., Desipramine: An Overview, Journal of Clinical Psychiatry, 45, pp. 3–7, 1984.
14.
American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, Washington, DC, 1980.
15.
BrotmanA. W.HerzogD. B., and WoodsS. W., Antidepressant Treatment of Bulimia: The Relationship between Binging and Depressive Symptomatology, Journal of Clinical Psychiatry, 45, pp. 7–9, 1984.
16.
GwirtsmanH. E.Roy-ByrneP.YagerJ., and GernerR., Neuroendocrine Abnormalities in Bulimia, American Journal of Psychiatry, 140, pp. 559–563, 1983.
17.
HerzogD. B., Are Anorexic and Bulimic Patients Depressed?American Journal of Psychiatry, 141, pp. 1594–1597, 1984.
18.
MitchellJ. E.PyleR. L.HatsakamiD., and BoutacoffL. I., The Dexamethazone Suppression Test in Patients with Bulimia, Journal of Clinical Psychiatry, 45, pp. 508–511, 1984.
19.
StewartJ. W.WalshB. T.WrightL.RooseS. P., and GlassmanA. H., An Open Trial of MAO Inhibitors in Bulimia, Journal of Clinical Psychiatry, 45, pp. 217–222, 1984.
20.
WalshB. T.StewartJ. W.WrightL.HarrisonW.RooseS. P., and GlassmanA. H., Treatment of Bulimia with Monoamine Oxidase Inhibitors, American Journal of Psychiatry, 139, pp. 1629–1630, 1982.
21.
WoldP., Trazodone in the Treatment of Bulimia, Journal of Clinical Psychiatry, 44, pp. 275–276, 1983.
22.
BremnerJ. D.AbrahamsL. M.CrupieJ. E.McCauleyA.ProctorR. C., and SathananthanG., Multicenter Double Blind Comparison of Nomifensine and Imipramine for Efficacy and Safety in Depressed Outpatients, Journal of Clinical Psychiatry, 45, pp. 56–59, 1984.
23.
GoldsteinP. J.BrauzerB.KentsmithD.RosenthalS., and CharalampousK. D., Double Blind Placebo Controlled Multicentre Evaluation of the Efficacy and Safety of Nomifensine in Depressed Outpatients, Journal of Clinical Psychiatry, 45, pp. 52–55, 1984.
24.
StewartJ. W.QuitkinF. M.LubowitzM. R.McGrathP. J.HarrisonW. M., and KleinD. F., Efficacy of Desipramine in Depressed Outpatients, Archives of General Psychiatry, 40, pp. 202–207, 1983.
25.
PyleR. L.MitchellJ. E., and EckertE. D., Bulimia: A Report of 34 Cases, Journal of Clinical Psychiatry, 42, pp. 60–64, 1981.
26.
HerjanicB. and ReichW. R., Development of a Structured Psychiatric Interview for Children. Agreement between Child and Parent on Individual Symptoms, Journal of Abnormal Child Psychology, 10, pp. 307–324, 1982.
27.
GarnerD. M.OlmsteadM. P., and PolivyJ., Development and Validation of a Multidimensional Eating Disorder Inventory for Anorexia Nervosa and Bulimia, International Journal of Eating Disorders, 2, pp. 15–34, 1983.
28.
GarnerD.OlmsteadM., and PolivyJ., The Eating Disorders Inventory: A Measure of Cognitive-Behavioural Dimensions of Anorexia Nervosa and Bulimia, in Anorexia Nervosa: Recent Developments in Research, DarbyP. L. (ed.), Alan R. Liss Inc., New York, pp. 173–184, 1983.
29.
RobinsL.HelzerJ. E.RatcliffeK. S., National Institute of Mental Health Diagnostic Interview Schedule, Archives of General Psychiatry, 38, pp. 381–389, 1981.
30.
DerogatisL. R.LipmanR. S.RickelsK., The Hopkins Symptom Checklist (HSCL), A Self-Report Symptom Inventory, Behavioural Science, 19, pp. 1–15, 1974.
31.
DerogatisL. R.RickelsK., and RockA. F., The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale, British Journal of Psychiatry, 128, pp. 280–289, 1976.
32.
McNairD.LorrM., and DropplemanL. F., Profile of Mood States, Educational and Institutional Testing Service, San Diego, 1971.
33.
ShachamS., A Shortened Version of the Profile of Mood States, Journal of Personality Assessment, 47, pp. 305–306, 1983.
34.
CarrollB. J.FeinbergM.GredenJ. F., A Specific Laboratory Test for the Diagnosis of Melancholia, Archives of General Psychiatry, 38, pp. 15–22, 1981.
35.
OrsulakP. J. and RushA. J., Clinical Use of the DST, American Association for Clinical Chemistry, pp. 1–4, 1983.
36.
NieN., SPSSX, McGraw-Hill, New York, 1983.
37.
Boskind-LodahlM. and WhiteW. C., The Definition and Treatment of Bulimarexia in College Women—A Pilot Study, College Health, 27, pp. 84–86, 1978.
38.
FairburnC. G., Bulimia: Its Epidemiology and Management, in Eating and Its Disorders, StunkardA. J. (ed.), Raven Press, New York, pp. 235–256, 1984.
39.
GarfinkelP. E.MoldofskyH., and GarnerD. M., The Heterogeneity of Anorexia Nervosa—Bulimia as a Distinct Subgroup, Archives of General Psychiatry, 37, pp. 1036–1040, 1980.
40.
GarnerD. M.OlmstedM. P., and GarfinkelP. E., Does Anorexia Nervosa Occur on a Continuum?International Journal of Eating Disorders, 2, pp. 11–19, 1983.
41.
JohnsonC. L.StuckeyM. K.LewisL. D., and SchwartzD. M., Bulimia: A Descriptive Survey of 316 Cases, International Journal of Eating Disorders, 2, pp. 3–16, 1983.
